7.61
+0.41
+(5.69%)
At close: April 9 at 4:00:02 PM EDT
7.24
-0.37
(-4.86%)
Pre-Market: 8:00:01 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 5 |
| Avg. Estimate | 0.1 | 0.11 | 0.47 | 0.71 |
| Low Estimate | 0.07 | 0.08 | 0.34 | 0.45 |
| High Estimate | 0.14 | 0.14 | 0.58 | 1.11 |
| Year Ago EPS | -0.07 | 0.01 | 0.04 | 0.47 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 6 |
| Avg. Estimate | 61.06M | 64.47M | 258.58M | 313.57M |
| Low Estimate | 59.1M | 63.2M | 255.8M | 290M |
| High Estimate | 62.1M | 66.2M | 261.1M | 394.71M |
| Year Ago Sales | 50.3M | 57.19M | 235.13M | 258.58M |
| Sales Growth (year/est) | 21.38% | 12.73% | 9.97% | 21.27% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.14 | 0.01 | 0.01 | -0.02 |
| EPS Actual | -0.07 | 0.01 | 0.1 | 0.01 |
| Difference | 0.07 | 0 | 0.09 | 0.03 |
| Surprise % | 48.78% | 20.05% | 566.67% | 162.50% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.1 | 0.11 | 0.47 | 0.71 |
| 7 Days Ago | 0.1 | 0.12 | 0.57 | 0.84 |
| 30 Days Ago | 0.11 | 0.13 | 0.57 | 0.87 |
| 60 Days Ago | 0.11 | 0.13 | 0.57 | 0.87 |
| 90 Days Ago | 0.11 | 0.13 | 0.57 | 0.87 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | 1 | 1 | 1 | 1 |
| Down Last 30 Days | 1 | 1 | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AUPH | 250.00% | 1,025.00% | 1,062.50% | 51.83% |
| S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Upgrades & Downgrades
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 9/16/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 9/9/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/6/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/1/2024 |
| Maintains | Cantor Fitzgerald: Overweight to Overweight | 2/23/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/22/2024 |
Related Tickers
TGTX TG Therapeutics, Inc.
35.85
+0.90%
SWTX SpringWorks Therapeutics, Inc.
37.12
+3.95%
INCY Incyte Corporation
58.86
+3.32%
ARDX Ardelyx, Inc.
4.5000
+3.93%
AVXL Anavex Life Sciences Corp.
8.72
+14.74%
TVTX Travere Therapeutics, Inc.
14.35
+1.41%
CYTK Cytokinetics, Incorporated
37.32
+7.95%
IOVA Iovance Biotherapeutics, Inc.
3.2700
+14.74%
ACAD ACADIA Pharmaceuticals Inc.
14.96
+6.10%
BBIO BridgeBio Pharma, Inc.
32.88
+9.09%